Aprea Therapeutics APRE
NASDAQ APRE
$0.72 -0.03 (-4.00%)
As of: Oct 1, 2026 · 3:59 PM EDT

Aprea Therapeutics (APRE) Accounts Payables (2018 - 2026)

Updated

Aprea Therapeutics' Accounts Payables was $935,139 in Q2 2026, down 21.8% from $1.2 million a year earlier and down 68.2% from the prior quarter.

Analysis

Aprea Therapeutics (APRE) Accounts Payables (2018 - 2026) Analysis & Trends

At the end of FY2025, Accounts Payables at Aprea Therapeutics came in at $713,668, down 47.2% from FY2024.

  • Accounts Payables shows a five-year compound annual growth rate of -30.8% (FY2020 to FY2025).
  • In earlier years, Accounts Payables was $1.35 million in FY2024 (-19.0%), $1.67 million in FY2023 (+98.2%), $842,754 in FY2022 (-52.5%) and $1.77 million in FY2021 (-60.6%).
  • Quarterly Accounts Payables has moved between $641,322 (Q3 2025) and $3.99 million (Q2 2022) over five years.
  • Compared with a year earlier, Accounts Payables was higher in three of the last eight quarters, with growth averaging 6.5%.
  • The best year-over-year quarter for Accounts Payables over five years was Q1 2026 (growth of 129.5%); the worst was Q2 2023 (a decline of 71.6%).
  • Per Business Quant data, APRE's Accounts Payables in the three quarters before Q2 2026 was $2.94 million (Q1 2026), $713,668 (Q4 2025) and $641,322 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Aprea Therapeutics 40.11 Mn 40.11 Mn - 935,139.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 935,139.00
Mar 31, 2026 2.94 Mn
Dec 31, 2025 713,668.00
Sep 30, 2025 641,322.00
Jun 30, 2025 1.20 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.35 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 964,327.00
Mar 31, 2024 1.32 Mn
Dec 31, 2023 1.67 Mn
Sep 30, 2023 862,552.00
Jun 30, 2023 1.13 Mn
Mar 31, 2023 826,027.00
Dec 31, 2022 842,754.00
Sep 30, 2022 1.14 Mn
Jun 30, 2022 3.99 Mn
Mar 31, 2022 1.99 Mn
Dec 31, 2021 1.77 Mn
Sep 30, 2021 2.55 Mn
API Access

Aprea Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=APRE&period=max&api_key=YOUR_API_KEY